Duke University Medical Center, United States
C. Rory Goodwin is the Director for Spinal Oncology, Surgical Director for the Duke Center for Brain and Spine Metastasis and an Assistant Professor at the Duke University Medical Center. Dr. Goodwin attended the University of Florida where he majored in Neurobiological Sciences and Business Administration with minors in Chemistry and Economics. He obtained his M.D. and Ph.D. in Neuroscience from the Johns Hopkins University School of Medicine while also leading, founding, and participating in programs focused on future and current underrepresented minority students including serving as National President for the Student National Medical Association. He completed his Neurosurgery residency at the Johns Hopkins Hospital and has received research awards from the UNCF-Merck Science Initiative and the Burroughs Wellcome Fund, Robert Wood Johnson Foundation, and the NIH. Over the course of his training, he served as a Medical Officer for the Food and Drug Administration, Division of Orthopedic Devices, graduated from the Global Clinical Scholars Research Training Program at Harvard Medical School and also completed an in-folded Complex Spine Fellowship at The Johns Hopkins Hospital. Dr. Goodwin has a research interest in translational biomarkers and clinical outcomes for patients diagnosed with spinal tumors, and genomic and proteomic predictors in brain and spinal oncology.